Product Name | YH-25448 |
Synonyms | Lazertinib;YH25448;GNS1480;4A2Y23XK11;N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide;N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide;N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide;Lazertinib [USAN];Lazertinib [I;Leclaza;Lazertinib [INN];Lazertinib (YH25448);GTPL10136;BCP30440;BDBM50555575;Lazertinib (YH25448,GNS-1480) |
Catalog No. | A-2819 |
CAS No. | 1903008-80-9 |
Molecular Formula | C30H34N8O3 |
Molecular Weight | 554.6428 |
Smile Code | CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC |
InChI | |
EINECS | |
Density | |
Melting point | |
Boiling point | |
Refractive index | |
Water solubility | |
Hazard Symbols | |
Risk Codes | |
Safety Description |